ICON Public Limited Company ICON Public Limited Company

ICON Public Limited Company

ICLR

Ранг среди акций #1655
ICON Public Limited Company, a clinical research organization, provides... ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Цена акции
$168.25
Последняя синхронизация: 2026-10-16
Рыночная капитализация
$12.98B
Изменение (1 день)
-3.93%
Изменение (1 год)
-9.08%
Страна
IE
Торговля ICON Public Limited Company (ICLR)

Категория

Healthcare
Операционная маржа для ICON Public Limited Company (ICLR)
Операционная маржа на October 2026 TTM: 10.15%
Согласно последним финансовым отчетам и цене акций ICON Public Limited Company, текущая операционная маржа (TTM) составляет 10.15%. В конце 2023 она составила 11.78%.
История операционной маржи ICON Public Limited Company с 2001 по 2026
Операционная маржа на конец каждого года
Год Операционная маржа Изменить
2026 (TTM) 10.15% -23.45%
2024 13.26% 12.56%
2023 11.78% 14.70%
2022 10.27% 48.63%
2021 6.91% -50.64%
2020 14.00% -9.39%
2019 15.45% 7.44%
2018 14.38% -25.26%
2017 19.24% 2.89%
2016 18.70% 4.59%
2015 17.88% 32.84%
2014 13.46% 48.40%
2013 9.07% 39.54%
2012 6.50% 56.63%
2011 4.15% -59.43%
2010 10.23% -15.52%
2009 12.11% 5.30%
2008 11.50% 4.74%
2007 10.98% 4.57%
2006 10.50% 83.57%
2005 5.72% -50.60%
2004 11.58% 4.89%
2003 11.04% -5.07%
2002 11.63% 22.04%
2001 9.53% 0.00%
Операционная маржа для аналогичных компаний или конкурентов
Компания Операционная маржа Разница в операционной марже Страна
17.97% -98.23%
US
20.42% -97.99%
US
-10.70% -101.05%
US
0.00% -
CN
22.23% -97.81%
US
Что такое операционная маржа компании?
Операционная маржа — это ключевой показатель прибыльности компании. Более высокая операционная маржа обычно означает, что компания может продавать свои товары или услуги значительно дороже их себестоимости. Она рассчитывается путем деления прибыли компании на её выручку.